About
EnsoData provides a comprehensive, AI-driven sleep medicine platform designed to support clinicians across the entire patient sleep journey—from initial diagnosis to ongoing therapy. The company's FDA-cleared Software as Medical Devices (SaMDs) include EnsoSleep, an AI scoring and cloud-based study management platform for polysomnograms (PSGs) and home sleep apnea tests (HSATs), and EnsoHST, a multi-night home sleep testing device capturing 8+ physiological signals including PPG, SpO2, HRV, actigraphy, snore, and more. EnsoSleep delivers an average 62% time savings on PSG scoring and 68% on HSATs, with clinically validated accuracy metrics such as 93% overall AHI agreement and 94% sleep-disordered breathing agreement. The platform is fully cloud-based, enabling multi-site access across devices, locations, and care teams. Celeste+, the companion FDA-cleared mobile application, facilitates data collection and transfer from pulse oximeters used in EnsoHST testing. Therapy Track rounds out the suite by enabling remote long-term monitoring and titration for CPAP, GLP-1s, HGNS, and oral appliances. EnsoData serves 500+ U.S. sleep centers and targets the estimated 54 million Americans and 425 million global patients living with undiagnosed or untreated obstructive sleep apnea. The platform is built for health systems, sleep labs, and independent sleep centers seeking to streamline operations and improve patient outcomes.
Key Features
- AI Sleep Scoring (EnsoSleep): Automatically scores PSGs and HSATs with FDA-cleared AI, achieving 93% AHI agreement and saving clinicians an average of 62–68% in scoring time.
- Multi-Night Home Sleep Testing (EnsoHST): Captures 8+ physiological signals—including PPG, SpO2, HRV, snore, and actigraphy—over up to 7 nights using comfortable ring and watch form factors to reduce night-to-night variability.
- Cloud-Based Study Management: Centralizes sleep study workflows across all devices, locations, and teams for faster clinical actions, report finalization, and multi-site collaboration.
- Therapy Track – Remote Monitoring & Titration: Enables clinicians to remotely monitor patient therapy progress and titrate CPAP, GLP-1s, HGNS, and oral appliances using the same devices used in diagnosis.
- Celeste+ Mobile Application: FDA-cleared companion app for EnsoHST that guides patients through data collection and securely transfers results for clinician review.
Use Cases
- Automating PSG and HSAT sleep study scoring to reduce clinician workload at high-volume sleep centers
- Conducting multi-night home sleep apnea testing for patients where single-night results are inconclusive
- Remotely monitoring and titrating CPAP and other sleep therapy devices for long-term patient management
- Streamlining sleep study workflows across multi-location health systems with a centralized cloud platform
- Expanding access to sleep apnea diagnosis for the estimated 80% of OSA patients who remain undiagnosed
Pros
- Significant Time Savings: AI scoring reduces PSG and HSAT processing time by over 60%, freeing clinicians for higher-value patient care tasks.
- Clinically Validated Accuracy: FDA-cleared with peer-reviewed clinical validation studies, giving health systems confidence in AI-generated sleep scoring results.
- End-to-End Sleep Journey Coverage: A unified platform covering home testing, in-lab scoring, and long-term therapy monitoring eliminates the need for multiple disconnected systems.
- Patient-Friendly Devices: Ring and watch form factors for home testing are comfortable and familiar, reducing patient burden and improving compliance.
Cons
- Enterprise-Only Pricing: Designed for health systems and sleep centers; no self-serve or individual clinician pricing is publicly available, making it inaccessible for smaller practices.
- Limited to Sleep Medicine: The platform is narrowly focused on sleep disorders, offering no utility outside of sleep medicine workflows.
- Hardware Dependency: Full functionality requires use of EnsoHST proprietary hardware, which may involve additional procurement and onboarding costs.
Frequently Asked Questions
Is EnsoData's AI sleep scoring FDA-cleared?
Yes, both EnsoSleep and EnsoHST are FDA-cleared Software as Medical Devices (SaMDs), validated through prospective clinical studies.
What physiological signals does EnsoHST measure?
EnsoHST captures 8+ signals including photoplethysmogram (PPG), SpO2, pulse rate, snore, acoustic flow, body position, HRV, and actigraphy.
How accurate is EnsoSleep's AI scoring?
EnsoSleep achieves 93% overall AHI agreement, 94% sleep-disordered breathing agreement, 86% sleep staging agreement, and 98% CSA agreement.
Can EnsoData be used for long-term therapy monitoring?
Yes. The Therapy Track feature enables remote monitoring and titration for CPAP, GLP-1s, hypoglossal nerve stimulation (HGNS), and oral appliances using the same patient devices from testing.
Who is EnsoData designed for?
EnsoData is designed for health systems, hospital-based sleep labs, and independent sleep centers with dedicated sleep medicine professionals managing high volumes of sleep studies.
